Cargando…

Persistence of positive severe acute respiratory syndrome coronavirus‐2 reverse transcription–polymerase chain reaction test result for 24 days in a hospitalized asymptomatic carrier

BACKGROUND: Several countries have imposed a mandatory 14‐day period of quarantine on individuals arriving from countries considered high‐risk for severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection. However, it is not clear how long asymptomatic patients infected with SARS‐CoV‐2...

Descripción completa

Detalles Bibliográficos
Autores principales: Uechi, Takahiro, Nakamura, Shunsuke, Takeshita, Ryo, Morino, Kyoko, Mizuno, Ren, Nakagawa, Yuki, Irifukuhama, Yuna, Takada, Shiho, Teruya, Hideki, Mita, Naoto, Nakamori, Tomoki, Kinoshita, Hirohisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276721/
https://www.ncbi.nlm.nih.gov/pubmed/32528710
http://dx.doi.org/10.1002/ams2.525
_version_ 1783543008309805056
author Uechi, Takahiro
Nakamura, Shunsuke
Takeshita, Ryo
Morino, Kyoko
Mizuno, Ren
Nakagawa, Yuki
Irifukuhama, Yuna
Takada, Shiho
Teruya, Hideki
Mita, Naoto
Nakamori, Tomoki
Kinoshita, Hirohisa
author_facet Uechi, Takahiro
Nakamura, Shunsuke
Takeshita, Ryo
Morino, Kyoko
Mizuno, Ren
Nakagawa, Yuki
Irifukuhama, Yuna
Takada, Shiho
Teruya, Hideki
Mita, Naoto
Nakamori, Tomoki
Kinoshita, Hirohisa
author_sort Uechi, Takahiro
collection PubMed
description BACKGROUND: Several countries have imposed a mandatory 14‐day period of quarantine on individuals arriving from countries considered high‐risk for severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection. However, it is not clear how long asymptomatic patients infected with SARS‐CoV‐2 can be an asymptomatic carrier. CASE PRESENTATION: We experienced a case of an asymptomatic female patient infected with SARS‐CoV‐2 with abnormal chest computed tomography findings. She did not develop a fever during hospitalized isolation. She remained reverse transcription–polymerase chain reaction‐positive for 24 days. CONCLUSION: An asymptomatic patient diagnosed with SARS‐CoV‐2 infection remained reverse transcription–polymerase chain reaction‐positive for 24 days, although she was quarantined in an isolation hospital. This finding suggests that an asymptomatic patient diagnosed with SARS‐CoV‐2 infection with abnormal chest computed tomography findings can be an asymptomatic carrier for more than 3 weeks.
format Online
Article
Text
id pubmed-7276721
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-72767212020-06-08 Persistence of positive severe acute respiratory syndrome coronavirus‐2 reverse transcription–polymerase chain reaction test result for 24 days in a hospitalized asymptomatic carrier Uechi, Takahiro Nakamura, Shunsuke Takeshita, Ryo Morino, Kyoko Mizuno, Ren Nakagawa, Yuki Irifukuhama, Yuna Takada, Shiho Teruya, Hideki Mita, Naoto Nakamori, Tomoki Kinoshita, Hirohisa Acute Med Surg Case Reports BACKGROUND: Several countries have imposed a mandatory 14‐day period of quarantine on individuals arriving from countries considered high‐risk for severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection. However, it is not clear how long asymptomatic patients infected with SARS‐CoV‐2 can be an asymptomatic carrier. CASE PRESENTATION: We experienced a case of an asymptomatic female patient infected with SARS‐CoV‐2 with abnormal chest computed tomography findings. She did not develop a fever during hospitalized isolation. She remained reverse transcription–polymerase chain reaction‐positive for 24 days. CONCLUSION: An asymptomatic patient diagnosed with SARS‐CoV‐2 infection remained reverse transcription–polymerase chain reaction‐positive for 24 days, although she was quarantined in an isolation hospital. This finding suggests that an asymptomatic patient diagnosed with SARS‐CoV‐2 infection with abnormal chest computed tomography findings can be an asymptomatic carrier for more than 3 weeks. John Wiley and Sons Inc. 2020-06-10 /pmc/articles/PMC7276721/ /pubmed/32528710 http://dx.doi.org/10.1002/ams2.525 Text en © 2020 The Authors. Acute Medicine & Surgery published by John Wiley & Sons Australia, Ltd on behalf of Japanese Association for Acute Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Reports
Uechi, Takahiro
Nakamura, Shunsuke
Takeshita, Ryo
Morino, Kyoko
Mizuno, Ren
Nakagawa, Yuki
Irifukuhama, Yuna
Takada, Shiho
Teruya, Hideki
Mita, Naoto
Nakamori, Tomoki
Kinoshita, Hirohisa
Persistence of positive severe acute respiratory syndrome coronavirus‐2 reverse transcription–polymerase chain reaction test result for 24 days in a hospitalized asymptomatic carrier
title Persistence of positive severe acute respiratory syndrome coronavirus‐2 reverse transcription–polymerase chain reaction test result for 24 days in a hospitalized asymptomatic carrier
title_full Persistence of positive severe acute respiratory syndrome coronavirus‐2 reverse transcription–polymerase chain reaction test result for 24 days in a hospitalized asymptomatic carrier
title_fullStr Persistence of positive severe acute respiratory syndrome coronavirus‐2 reverse transcription–polymerase chain reaction test result for 24 days in a hospitalized asymptomatic carrier
title_full_unstemmed Persistence of positive severe acute respiratory syndrome coronavirus‐2 reverse transcription–polymerase chain reaction test result for 24 days in a hospitalized asymptomatic carrier
title_short Persistence of positive severe acute respiratory syndrome coronavirus‐2 reverse transcription–polymerase chain reaction test result for 24 days in a hospitalized asymptomatic carrier
title_sort persistence of positive severe acute respiratory syndrome coronavirus‐2 reverse transcription–polymerase chain reaction test result for 24 days in a hospitalized asymptomatic carrier
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276721/
https://www.ncbi.nlm.nih.gov/pubmed/32528710
http://dx.doi.org/10.1002/ams2.525
work_keys_str_mv AT uechitakahiro persistenceofpositivesevereacuterespiratorysyndromecoronavirus2reversetranscriptionpolymerasechainreactiontestresultfor24daysinahospitalizedasymptomaticcarrier
AT nakamurashunsuke persistenceofpositivesevereacuterespiratorysyndromecoronavirus2reversetranscriptionpolymerasechainreactiontestresultfor24daysinahospitalizedasymptomaticcarrier
AT takeshitaryo persistenceofpositivesevereacuterespiratorysyndromecoronavirus2reversetranscriptionpolymerasechainreactiontestresultfor24daysinahospitalizedasymptomaticcarrier
AT morinokyoko persistenceofpositivesevereacuterespiratorysyndromecoronavirus2reversetranscriptionpolymerasechainreactiontestresultfor24daysinahospitalizedasymptomaticcarrier
AT mizunoren persistenceofpositivesevereacuterespiratorysyndromecoronavirus2reversetranscriptionpolymerasechainreactiontestresultfor24daysinahospitalizedasymptomaticcarrier
AT nakagawayuki persistenceofpositivesevereacuterespiratorysyndromecoronavirus2reversetranscriptionpolymerasechainreactiontestresultfor24daysinahospitalizedasymptomaticcarrier
AT irifukuhamayuna persistenceofpositivesevereacuterespiratorysyndromecoronavirus2reversetranscriptionpolymerasechainreactiontestresultfor24daysinahospitalizedasymptomaticcarrier
AT takadashiho persistenceofpositivesevereacuterespiratorysyndromecoronavirus2reversetranscriptionpolymerasechainreactiontestresultfor24daysinahospitalizedasymptomaticcarrier
AT teruyahideki persistenceofpositivesevereacuterespiratorysyndromecoronavirus2reversetranscriptionpolymerasechainreactiontestresultfor24daysinahospitalizedasymptomaticcarrier
AT mitanaoto persistenceofpositivesevereacuterespiratorysyndromecoronavirus2reversetranscriptionpolymerasechainreactiontestresultfor24daysinahospitalizedasymptomaticcarrier
AT nakamoritomoki persistenceofpositivesevereacuterespiratorysyndromecoronavirus2reversetranscriptionpolymerasechainreactiontestresultfor24daysinahospitalizedasymptomaticcarrier
AT kinoshitahirohisa persistenceofpositivesevereacuterespiratorysyndromecoronavirus2reversetranscriptionpolymerasechainreactiontestresultfor24daysinahospitalizedasymptomaticcarrier